MENU
AGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Agenus (AGEN) Ownership - Who owns Agenus?

Industry: @Biotechnology

Profile

Industry
Biotechnology
Address
3 Forbes Road
Phone
+1 781 674-4400
Employees
389
Web
https://www.agenusbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
59.75M
P/E Ratio
0.45
Total Cash
N/A
Projected Growth
N/A
Total Debt
88.88M
Revenue
N/A
Risk (Beta)
1.47
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
14.79
Revenue/Share
7.81 USD as % of share price

Fundamentals

AGEN
Capitalization
59.8M
P/E Ratio
0.45
Risk (Beta)
1.47
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
88.9M
Total Debt/Equity
14.79
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.81%
Revenue
N/A
ROE
N/A
Book Value
-201.43M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
210K
Current Ratio
0.24
Current Revenue Per Employee
71992.29
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
-57.23
Revenue To Assets
N/A
Shares Held By Institutions
181M
Shares Outstanding - Current
21.6M
Total Liabilities
45.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-83.271
View a ticker or compare two or three
AGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of technologies to treat cancers and infectious diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3 Forbes Road
Phone
+1 781 674-4400
Employees
389
Web
https://www.agenusbio.com